CL
Clene Inc.
CLNNW · NASDAQ
$0.00 -28.00% (-$0.00)
Market Cap $2.16M
P/E Ratio -
Div. Yield -
ROE 351.16%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 10.11x
EV/EBITDA N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 14,250.50%
Op. margin 11,328.50%
FCF margin 8,694.91%
Quality
30 /100
Poor ROE 351.16%
ROA 136.69%
Asset turnover 0.01x
Debt
66 /100
Moderate Int. coverage -11.44x
Net debt/EBITDA -0.51x
Current ratio 1.53x
Stability
55 /100
Moderate EPS volatility 46.31%
Profitable years 0
Beta 0.79x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na CLNNW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Robert Etherington
Employees
75
Headquarters
Salt Lake City